Prosperdtx Launches Strategic Collaboration With Health Equity Researchers and Seqster to Improve Health Equity for Cancer Patients
Retrieved on:
Wednesday, May 18, 2022
Nanotechnology, Other Science, Pharmaceutical, Research, Insurance, Oncology, Software, Finance, Hardware, Hospitals, Data Management, Professional Services, Science, Technology, Managed Care, Biotechnology, Surgery, Health, Assistant, Education, DNA, Trial of the century, Research, Social media, Lucile Adams-Campbell, Healthcare disparity in Massachusetts, Patient, Survivor, Health, Office, List of life sciences, Associate, Patient engagement in Canada, Pharmacy, Laika (EHR testing framework), Instagram, Digital technology, YouTube, Communication, Hospital, Digital health, Forward-looking statement, Therapy, LinkedIn, Twitter, Cancer, Health equity, Office of Minority Health, District, CEO, Pharmaceutical industry, Medical imaging, Asian Americans, Facebook
Our collaboration with Seqster will enable us to demonstrate how Prosperdtxs digital health platform can help cancer patients live better lives with improved and cost-effective health outcomes.
Key Points:
- Our collaboration with Seqster will enable us to demonstrate how Prosperdtxs digital health platform can help cancer patients live better lives with improved and cost-effective health outcomes.
- Seqsters Operating System will enable Prosperdtx to deliver precision cancer care to cancer patients in real-time, said Joseph Swiader, co-founder and CEO of Prosperdtx.
- Prosperdtx is maximizing the continuity of cancer care so that patients can live longer, better lives while reducing the cost of healthcare.
- Seqster has nationwide coverage of EHRs from hospitals and medical groups, genomic DNA, wearables, pharmacy, and social determinants of health data.